Propylthiouracil-Induced Skin Vasculitis
- PMID: 36000132
- PMCID: PMC9390865
- DOI: 10.7759/cureus.27073
Propylthiouracil-Induced Skin Vasculitis
Abstract
The use of propylthiouracil (PTU) is associated with the development of autoantibodies, namely, antineutrophil cytoplasmic antibodies (ANCAs), which are associated with the pathogenesis of ANCA-associated systemic vasculitis, most often related to the myeloperoxidase subtype (ANCA-MPO). The authors report the case of a 61-year-old woman on PTU for one year who was referred to Internal Medicine for a three-month evolution of painless non-blanching purple patches, non-pruriginous, involving the chest and legs. The autoimmunity revealed ANCA antibody positivity, with a cutaneous biopsy compatible with leukocytoclastic vasculitis/necrotizing vasculitis with involvement of small and medium-sized vessels. Clinical improvement was noted after the drug was discontinued, with the resolution of the analytical changes.
Keywords: adverse reactions; anca; antibodies; propylthiouracil; purpuric plaques; vasculitis.
Copyright © 2022, Almeida et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- The safety and efficacy of antithyroid drugs. Azizi F. Expert Opin Drug Saf. 2006;5:107–116. - PubMed
-
- Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. Chen M, Gao Y, Guo XH, Zhao MH. Nat Rev Nephrol. 2012;8:476–483. - PubMed
-
- [Propylthiouracil-induced cutaneous vasculitis] Milanez FM, Gonçalves A. Costa LA, José FF, Enokihara MM, Silva de Souza AQ. Rev Bras Reumatol. 2008;48:55–58.
-
- Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis mimicking Kawasaki disease. Aoki Y, Kitazawa K, Kobayashi H. Paediatr Int Child Health. 2019;39:142–145. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous